US 11,654,131 B1
Composition and method of treatment of health issues related to estrogen metabolism with elevated risk factors in females
Aleksandra Niedzwiecki, Henderson, NV (US); Matthias W Rath, Henderson, NV (US); Parthena Boulikas, Sanjose, CA (US); Anna Goc, Sanjose, CA (US); and Gabriela Lopez, Oakland, CA (US)
Assigned to Matthias W. Rath, Henderson, NV (US)
Filed by Matthias W Rath, Henderson, NV (US)
Filed on Oct. 17, 2022, as Appl. No. 17/966,901.
Claims priority of provisional application 63/338,043, filed on May 4, 2022.
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/375 (2006.01); A61P 35/00 (2006.01); A61K 31/355 (2006.01); A61K 31/197 (2006.01); A61K 31/675 (2006.01); A61K 31/519 (2006.01); A61K 33/18 (2006.01); A61K 33/04 (2006.01); A61K 31/14 (2006.01); A61K 31/047 (2006.01); A61K 31/685 (2006.01); A61K 31/353 (2006.01); A61K 36/48 (2006.01); A61K 36/537 (2006.01); A61K 36/53 (2006.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A23L 33/125 (2016.01); A23L 33/105 (2016.01); A61P 5/24 (2006.01)
CPC A61K 31/375 (2013.01) [A23L 33/105 (2016.08); A23L 33/125 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A61K 31/047 (2013.01); A61K 31/14 (2013.01); A61K 31/197 (2013.01); A61K 31/353 (2013.01); A61K 31/355 (2013.01); A61K 31/519 (2013.01); A61K 31/675 (2013.01); A61K 31/685 (2013.01); A61K 33/04 (2013.01); A61K 33/18 (2013.01); A61K 36/48 (2013.01); A61K 36/53 (2013.01); A61K 36/537 (2013.01); A61P 5/24 (2018.01); A61P 35/00 (2018.01); A23V 2002/00 (2013.01)] 12 Claims
 
1. A micronutrient mixture, consisting of:
Vitamin C in ascorbate form, Vitamin E in D-alpha-tocopherol form, Vitamin B5, Vitamin B6, Folic acid, Iodine, Selenium, Choline, Inositol, Phosphatidyl serine, Soy extract containing Daidzein, Glycitein, Genistein, Red clover, Rosemary extract, and Chaste tree berry and optionally one or a combination of pharmaceutically acceptable carriers, excipient, liquefied propellant, buffer, pH regulator, stabilizer, coating or flavoring agent, wherein the micronutrient mixture is formulated as a tablet, coated tablet, capsule, pill, intranasal, lozenges, emulsion, pastilles, suppository, paste or injectable solution.